Found: 14
Select item for more details and to access through your institution.
The effectiveness and safety of introducing condom-catheter uterine balloon tamponade for postpartum haemorrhage at secondary level hospitals in Uganda, Egypt and Senegal: a stepped wedge, cluster-randomised trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Misoprostol for primary versus secondary prevention of postpartum haemorrhage: a cluster-randomised non-inferiority community trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
O294 NATIONAL EXPANSION STUDY OF MEDICAL ABORTION TO 63 DAYS LMP IN TUNISIAN FAMILY PLANNING CLINICS
- Published in:
- 2012
- By:
- Publication type:
- Abstract
O155 OUTCOMES OF A DOUBLE-BLIND RANDOMIZED TRIAL COMPARING MISOPROSTOL-ONLY TO MIFEPRISTONE+MISOPROSTOL FOR HOME-BASED EARLY MEDICAL ABORTION
- Published in:
- 2012
- By:
- Publication type:
- Abstract
I080 PROGRAMMATIC IMPLICATIONS OF CURRENT STRATEGIES AND NEW APPROACHES TO INTEGRATING MISOPROSTOL FOR PPH MANAGEMENT
- Published in:
- 2012
- By:
- Publication type:
- Abstract
I081 DOES ROUTE MATTER? WHAT WE KNOW ABOUT FIRST TRIMESTER MEDICAL ABORTION OUTCOMES WITH REGIMENS USING VARIOUS ROUTES OF MISOPROSTOL ADMINISTRATION
- Published in:
- 2012
- By:
- Publication type:
- Abstract
Comparison of misoprostol-only and combined mifepristone-misoprostol regimens for home-based early medical abortion in Tunisia and Vietnam.
- Published in:
- 2012
- By:
- Publication type:
- journal article
P229 The effect of active management on postpartum blood loss in a Turkish maternity hospital
- Published in:
- 2009
- By:
- Publication type:
- Abstract
O202 Bleeding following surgical (MVA) and medical (400 μg sublingual misoprostol) treatment of incomplete abortion
- Published in:
- 2009
- By:
- Publication type:
- Abstract
O201 Side effect profiles for misoprostol and oxytocin in the treatment of postpartum hemorrhage
- Published in:
- 2009
- By:
- Publication type:
- Abstract
O172 A randomized controlled study of sublingual vs. oral misoprostol (400 μg) following mifepristone (200 mg) for medical abortion up to 63 days L.M.P. in Tunisia
- Published in:
- 2009
- By:
- Publication type:
- Abstract
I237 Treatment of postpartum hemorrhage with sublingual misoprostol versus oxytocin: Results from a randomized, non-inferiority trial among women not exposed to oxytocin during labor
- Published in:
- 2009
- By:
- Publication type:
- Abstract
I93 Understanding postpartum hemorrhage: Its frequency and treatment
- Published in:
- 2009
- By:
- Publication type:
- Abstract
I86 Treatment of postpartum hemorrhage with sublingual misoprostol versus oxytocin: Results from a randomized non-inferiority trial among women receiving prophylactic oxytocin
- Published in:
- 2009
- By:
- Publication type:
- Abstract